We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
The GEO Group
GEO
$4.04B
| $2.86M | ﹤0.01% |
399,741
-11,181
| -3% | -$86.7K |
|
1702
Winmark
WINA
$1.32B
| $2.86M | ﹤0.01% |
8,595
-73
| -0.8% | -$24.7K |
|
1703
Agios Pharmaceuticals
AGIO
$1.93B
| $2.86M | ﹤0.01% |
100,882
+9,477
| +10% | +$236K |
|
|
AKRO
1704
DELISTED
Akero Therapeutics
AKRO
| $2.86M | ﹤0.01% |
61,174
+6,303
| +11% | +$289K |
|
1705
Caleres
CAL
$487M
| $2.86M | ﹤0.01% |
119,356
+7,141
| +6% | +$160K |
|
1706
Arlo Technologies
ARLO
$1.65B
| $2.85M | ﹤0.01% |
261,433
+5,039
| +2% | +$41K |
|
1707
Green Dot
GDOT
$745M
| $2.85M | ﹤0.01% |
152,098
-2,893
| -2% | -$51.3K |
|
1708
Metallus
MTUS
$898M
| $2.85M | ﹤0.01% |
131,925
-5,704
| -4% | -$103K |
|
1709
Banco Bradesco
BBD
$36.7B
| $2.84M | ﹤0.01% |
+820,936
| New | +$2.54M |
|
1710
iShares Core S&P Small-Cap ETF
IJR
$112B
| $2.84M | ﹤0.01% |
28,462
+6,743
| +31% | +$642K |
|
1711
Appian
APPN
$2.48B
| $2.83M | ﹤0.01% |
59,393
+2,812
| +5% | +$119K |
|
1712
Kforce
KFRC
$1.06B
| $2.82M | ﹤0.01% |
45,058
+612
| +1% | +$36.9K |
|
1713
Quanex
NX
$1.01B
| $2.82M | ﹤0.01% |
105,028
-4,464
| -4% | -$99.3K |
|
|
NXGN
1714
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.82M | ﹤0.01% |
173,763
+6,093
| +4% | +$101K |
|
1715
Customers Bancorp
CUBI
$2.77B
| $2.82M | ﹤0.01% |
93,121
-4,207
| -4% | -$94.3K |
|
1716
ZTO Express
ZTO
$17.9B
| $2.81M | ﹤0.01% |
+112,193
| New | +$3.09M |
|
|
CERE
1717
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.81M | ﹤0.01% |
88,268
+4,546
| +5% | +$140K |
|
1718
Impinj
PI
$5.6B
| $2.8M | ﹤0.01% |
31,239
+1,085
| +4% | +$116K |
|
|
CCF
1719
DELISTED
Chase Corporation
CCF
| $2.8M | ﹤0.01% |
23,097
-676
| -3% | -$77.7K |
|
|
AVTA
1720
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.79M | ﹤0.01% |
124,457
-7,499
| -6% | -$177K |
|
1721
SAP
SAP
$238B
| $2.78M | ﹤0.01% |
+20,316
| New | +$2.69M |
|
1722
Mativ Holdings
MATV
$711M
| $2.77M | ﹤0.01% |
183,526
-2,910
| -2% | -$51.5K |
|
1723
Ambev
ABEV
$46.4B
| $2.77M | ﹤0.01% |
+872,129
| New | +$2.57M |
|
1724
Bumble
BMBL
$373M
| $2.77M | ﹤0.01% |
164,989
+8,945
| +6% | +$154K |
|
1725
Toyota
TM
$225B
| $2.76M | ﹤0.01% |
+17,180
| New | +$2.47M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.